Preview Mode Links will not work in preview mode

Keeping Current CME


Jan 17, 2024

Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies.

Credit available for this activity expires: 1/12/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu